Read an exclusive interview with Microbiotica CEO Mike Romanos published by Microbiome Movement. The interview covers the exciting developments in the microbiome space, Microbiotica’s progress over the past year, and a forward look at the Company’s aims in the next 12 months.
Cambridge, UK, 24 February 2021 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, announces the appointment of Hans Schikan as Non-Executive Chairman, effective immediately. Hans brings decades of commercial, development, transactional and leadership experience from the biopharma industry. He is a well-established biopharma leader, having held many board memberships on both private and […]
Ronald Carter, MD appointed as Chief Medical Officer Tim Sharpington appointed as Chief Operating Officer Cambridge, UK, 04 February 2021 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces the appointment of Ronald Carter, MD, as Chief Medical Officer (CMO), and the appointment of Tim Sharpington as Chief Operating Officer (COO). Ron […]
Cambridge, UK, 18 September 2020 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, has been named Business Weekly Young Company of the Year 2020. The “Young Company of the Year” category is awarded to the most exciting recently incorporated enterprise in any sector that has made significant progress in the last 12 months. […]
Cambridge, UK, 9 September 2020 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, been selected as a finalist in the ‘Best Emerging Biotech Company’ category at the OBN Awards 2020. The winners will be announced on Thursday 26th November. Microbiotica has established itself as a leading global player in its field, and most […]
Cambridge, UK, 13 August 2020 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today congratulates Co-founder Gordon Dougan, FRS, Professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge, on being awarded the 2020 Albert B. Sabin Gold Medal. The Gold Medal, […]
BIO Digital Jun 8 to Jun 12, 2020 Virtual Event More information
Collaboration in immuno-oncology microbiome therapeutic and biomarker development Partnership based on class-leading MELRESIST melanoma study and new MITRE landmark study in 1,800 patients in multiple cancers Uses Microbiotica’s unrivalled microbiome platform Cambridge, UK, 8 June 2020 – Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, Cancer Research UK and Cambridge University Hospitals NHS Foundation […]
Microbiome Connect Human USA Jun 3 to Jun 5, 2020 Boston, USA More Information
Cambridge, UK, 14 May 2020 – It was with great sadness that the Board of Microbiotica learned of the death of its Chairman, Thomas Lynch, who passed away on 1st April 2020. Thomas had been Chairman of Microbiotica since September 2019 and brought a wealth of experience and guidance to the Board. Thomas had a highly […]
Find us on LinkedIn
info@microbiotica.com